Results 1-18 of 18 for hpv speaker:Michael Harty

Joint Oireachtas Committee on Health: Royal College of Obstetricians and Gynaecologists Independent Expert Panel Review into Cervical Screening: Discussion (18 Dec 2019)

Michael Harty: ...of risk is a dynamic assessment that is changing all the time, and that we should be looking at the programme and improving it as it progresses? For instance, we are going to move from cytology to HPV testing, which reduces the risk of missed cases. Is Dr. Holohan saying that there is a constant review of the balance of risk?

Acknowledgement and Apology to Women and Families affected by CervicalCheck Debacle: Statements (22 Oct 2019)

Michael Harty: .... This is true of every screening programme. A missed case does not necessarily mean negligence was involved. It is extremely important that we move to a much more accurate test, that is, the HPV screening test. That will allow us to repatriate our screening to Ireland, where it should be. I am aware of no country in the world that outsources screening as we do. It is extremely...

Joint Oireachtas Committee on Health: Update on the CervicalCheck Screening Programme: Discussion (18 Sep 2019)

Michael Harty: ...substantial risk to the service because if anything happens to it, the cervical screening programme will be in serious trouble. How is that risk being managed? Is Quest Diagnostics involved in HPV testing, in addition to cytology? When doctors received results from MedLab Pathology, not only did they receive the cytology report, they also received a HPV report in conjunction with it....

Joint Oireachtas Committee on Health: Update on the CervicalCheck Screening Programme: Discussion (18 Sep 2019)

Michael Harty: ...first meaningful response was on 6 June when she threatened to go to the media. It took another three weeks, I understand, for her GP to get the report of her testing, which all revolved around HPV secondary testing.

CervicalCheck: Statements (9 May 2019)

Michael Harty: ...some days ago to discuss this very issue. Has the judgment really damaged the future of all screening? I believe there will be an appeal of the judgment. Will the Minister comment on that? HPV testing has been promised for a year. It was to come in last October and it is now promised for before the end of this year. What are the barriers to introducing HPV testing before the end...

Select Committee on Health: Estimates for Public Services 2019
Vote 38 - Health (Further Revised) (10 Apr 2019)

Michael Harty: I come back to the Estimates, the topic for today. The briefing document states that funding has been provided for CervicalCheck and the introduction of HPV testing as a primary screening test. Perhaps the Minister will elaborate on that and how close are we to moving towards HPV testing, which will revolutionise the screening programme and reduce the burden on cytology which is the reason...

Select Committee on Health: Estimates for Public Services 2019
Vote 38 - Health (Further Revised) (10 Apr 2019)

Michael Harty: I asked about the funding for CervicalCheck and the roll-out of HPV testing.

Select Committee on Health: Estimates for Public Services 2019
Vote 38 - Health (Further Revised) (10 Apr 2019)

Michael Harty: HPV testing was to start in October 2018.

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme Update: Discussion (Resumed) (3 Apr 2019)

Michael Harty: ...representatives of the HSE and CervicalCheck to receive an update on the CervicalCheck programme. The committee has expressed a particular interest in hearing about the proposed introduction of HPV testing for cervical screening and in discussing delayed smear reporting. On behalf of the committee, I welcome Mr. Damien McCallion, national director of screening services, Dr. Colm Henry,...

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme Update: Discussion (Resumed) (3 Apr 2019)

Michael Harty: ...cancer. In population health the population benefits, but the individual may not benefit. The majority of individuals do, however. We are talking about the backlog and the idea of moving towards HPV testing. I gather from our discussion this morning that those topics are interlinked, and until we clear the backlog and stabilise the situation we cannot really move on to HPV testing,...

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme Update: Discussion (Resumed) (3 Apr 2019)

Michael Harty: There is no timeline for moving to HPV testing because CervicalCheck cannot do that until it has stabilised the existing system. It could be a number of years, therefore, before we move to HPV testing.

Joint Oireachtas Committee on Health: National Cancer Strategy: Discussion (13 Mar 2019)

Michael Harty: ...from 70% to 75%. How can we increase those figures, given that it is a substantial gap in the cancer programme if we cannot recruit 100% participation? The Government had proposed to introduce HPV testing of cervical smears in October of last year but that has yet to happen and, according to what I have heard from the Minister for Health, it may not happen this year. Dr. Coffey might...

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme: Discussion (16 May 2018)

Michael Harty: ...delayed diagnosis and delayed treatment in the CervicalCheck programme, in other words, in the process of recall, getting appointments and access to colposcopy? Why is the proposed introduction of HPV testing of smears being delayed until November of this year? Surely that test could be introduced sooner.

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme: Discussion (16 May 2018)

Michael Harty: I am sorry, but to return to HPV testing, is it not a combination of HPV testing and cytology that is to be instituted?

HPV Vaccine: Motion [Private Members] (28 Mar 2018)

Michael Harty: I will speak in favour of this motion. The human papilloma virus, HPV, causes cervical cancer and a vaccine to prevent such a cancer is welcome. HPV is sexually transmitted and, therefore, it makes absolute sense that both boys and girls should be vaccinated against this virus. This would have two effects. First, it would reduce the transmission of the virus; and, second, it would reduce...

Joint Oireachtas Committee on Health: National Cancer Registry Board: Chairperson Designate (31 May 2017)

Michael Harty: In respect of HPV vaccination, is there a plan to extend it to boys?

Joint Oireachtas Committee on Health: Vaccination Programme: Discussion (11 May 2017)

Michael Harty: ...effect. That seems to be the barrier that I come across in giving pregnant women the influenza vaccine. Is it possible that it could be promoted through the ante-natal clinics? Second, on HPV, is there a programme envisaged to offer HPV vaccine to boys? On the HPV vaccine and the problems that are causing a reduction in uptake, the Minister has announced that he is going to develop a...

Select Committee on Health: Estimates for Public Services 2017
Vote 38 - Health (Revised) (2 Mar 2017)

Michael Harty: ...and therapists. Lastly, on health and well-being, the graphic refers specifically to vaccination and I will concentrate on that. There is a vaccine which is in serious trouble, that is, the HPV vaccine for the prevention of cervical cancer. The HPV vaccine could possibly reduce the incidence of cervical cancer, which is associated with the HPV virus that is implicated in 70% of...